An Open Label, Multicenter Safety and Efficacy Phase II/III Study of PRL3-Zumab in Solid Tumors Patients
Solid tumor
Kuala Lumpur...
Hemato-Oncology
28
Dec
A Phase 2b, Open-label, Multicenter, Randomized, Controlled, 2-Arm Study to Assess the Efficacy and Safety of Orally Administered NS-...
Others
12
Nov
Marker Assisted Selective ThErapy in Rare cancers: Knowledge database Establishing registrY Protocol
Kuala Lumpur Hospital (HKL)
...
Lung Cancer
23
Sep
Real-World Utilization and Outcomes with Dacomitinib First-Line Treatment for EGFR Mutation-Positive Advanced Non-Small Cell Lung Can...
Rare Cancers
23
Sep
Promoting genomic medicine throughout Asia (MASTER KEY ASIA)
University of Malaya Medical Centre (UMMC)
PRINCIPAL INVESTIGATOR
D...
Nasopharyngeal Carcinoma
23
Sep
Asian multicenter prospective study of circulating tumor DNA sequencing (A-TRAIN Nasopharyngeal Carcinoma Project)
Nasopharyngeal Ca...
Cervical Cancer Ovarian Clear Cell Carcinoma N
23
Sep
Asian Multicenter Prospective Study of Circulating Tumor DNA Sequencing (A-TRAIN)
Metastatic and/or Recurrent Disease
University ...
Prostate Cancer
23
Sep
Biomarker Study to Determine Frequency of DNA-repair Defects in Men with Metastatic Prostate Cancer (Observational) (PREVALENCE)
Met...
Breast Cancer
22
Sep
Studies of Epigenetic Changes in Blood Samples in Breast Cancer Patients (EPIGENECTIC)
Breast Cancer
Kuala Lumpur Hospital (HKL)
...